Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.45 |
| ▸ | PPARG | P37231 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | RXRA | P19793 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.42 |
| ▸ | F7 | P08709 | 3/20 | 0.42 |
| ▸ | F3 | P13726 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16580123 | 1.00 | OXER1 (0.51) | OXER1ADORA3NR1I2PTGS2PGR | |
| SCHEMBL17676486 | 1.00 | OXER1 (0.51) | OXER1ADORA3NR1I2PTGS2PGR | |
| SCHEMBL872828 | 0.93 | — | — | |
| SCHEMBL872827 | 0.93 | — | — | |
| SCHEMBL813287 | 0.93 | — | — | |
| SCHEMBL820772 | 0.91 | CYP4F2 (0.46) | OXER1ALDH1A1MAPTCYP3A4ALOX15 | |
| SCHEMBL12670444 | 0.91 | OXER1 (0.45) | OXER1ADORA3NR1I2PTGS2PGR | |
| SCHEMBL12670448 | 0.91 | OXER1 (0.45) | OXER1ADORA3NR1I2PTGS2PGR | |
| SCHEMBL17612150 | 0.91 | ALDH1A1 (0.57) | OXER1ADORA3NR1I2PTGS2PGR | |
| SCHEMBL30986796 | 0.91 | ADORA3 (0.56) | OXER1ADORA3NR1I2PTGS2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150284313-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-08 | — | — | US | disclosed |
| US-8841360-B2 | Enzyme curable alkyd composition | ROHM AND HAAS COMPANY (US) | 2014-09-23 | — | — | US | disclosed |
| US-8067623-B2 | Producing waxes from soybean oil; ruthenium alkylidene catalytic, simultaneous opening and inserting | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | WILMAR TRADING PTE LTD (SG) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | SQLE, COASY, ALOX12 | OXER1 8/4885ADORA3 4112/4885NR1I2 2200/4885 |
| US-20150284313-A1 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | DDC, LTC4S, CYCS | OXER1 891/4885ADORA3 1205/4885NR1I2 1770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.